Cargando…
Spectrum of BRCA1 interacting helicase 1 aberrations and potential prognostic and therapeutic implication: a pan cancer analysis
BRCA1 interacting helicase 1 (BRIP1) alteration was crucial in tumors and it was a potential therapeutic target in ovarian serous cystadenocarcinoma (OV). Although a small number of studies had focused on BRIP1, an extensive study of BRIP1 genetic mutation and its clinical application in different c...
Autores principales: | Long, Guo, Hu, Kuan, Zhang, Xiaofang, Zhou, Ledu, Li, Juanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10023799/ https://www.ncbi.nlm.nih.gov/pubmed/36932143 http://dx.doi.org/10.1038/s41598-023-31109-6 |
Ejemplares similares
-
An integrative pan cancer analysis of RET aberrations and their potential clinical implications
por: Zhou, Lei, et al.
Publicado: (2022) -
Integrative pan-cancer analysis of MEK1 aberrations and the potential clinical implications
por: Zhou, Zhiyang, et al.
Publicado: (2021) -
Multimolecular characteristics and role of BRCA1 interacting protein C-terminal helicase 1 (BRIP1) in human tumors: a pan-cancer analysis
por: Wang, Ruohuang, et al.
Publicado: (2023) -
Spectrum of Mesenchymal–Epithelial Transition Aberrations and Potential Clinical Implications: Insights From Integrative Pancancer Analysis
por: Li, Juanni, et al.
Publicado: (2020) -
Insights of fibroblast growth factor receptor 3 aberrations in pan-cancer and their roles in potential clinical treatment
por: Li, Juanni, et al.
Publicado: (2021)